10 April 2006
Derivation of embryonic stem cells for cellular therapy: Challenges and newstrategies.
Philippe TaupinMed Sci Monit 2006; 12(4): RA75-78 :: ID: 448936
Abstract
Cellular therapy is the replacement of unhealthy or damaged cells or tissuesby new ones. Embryonic stem (ES) cells are undifferentiated cells that can generate all the cell typesof the body, and therefore hold the potential to cure a broad range of diseases and injuries, rangingfrom diabetis, liver and heart diseases, to neurological diseases, such as Alzheimer's and Parkinson'sdiseases. The derivation of human ES (hES) cells has been a major step toward bringing ES cell researchto therapy. However, there are several challenges to the advent of ES cell research to therapy. Amongthem, the derivation of hES cell lines devoid of animal contaminants, the maintenance of their normalkaryotypes, their potentials to form tumors upon grafting, and the derivation of isogenic hES cell lines.Stringent ethical and political guidelines are also limiting the use of human embryos for research, therebylimiting progress in ES cell research. Recently, several investigators have devised protocols to derivehES cells free of feeder layer and animal serum, reported that some established cell lines remain stableovertime, pre-differentiated ES cells in vitro to circumvent the risk of tumor formation, and derivedES cell lines without destroying embryos. In this manuscript, we will review and discuss these developmentsthat may unlock ES cell research and therapy.
Keywords: Cell Line, Cloning, Organism - ethics, Nuclear Transfer Techniques, Stem Cells - cytology
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952